Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Boosting resilience and reducing chronic low back pain by treating sleep and adding meditation or pain education

Official title: An Adaptive Intervention to Improve Pain Outcomes Following Cognitive Behavioral Therapy for Insomnia in Patients With Comorbid Chronic Low Back Pain and Insomnia

Run by University of Virginia · NCT07298941 · Data updated 2026-11-12

This program tests whether adding savoring meditation or extra pain education to a cognitive behavioral sleep program helps adults with chronic low back pain and insomnia have less pain.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorUniversity of Virginia
Academic / other
Locations1 site (Charlottesville, Virginia)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedOctober 30, 2029
Study endsApril 30, 2030
Registry record updatedDecember 23, 2025
Trial IDNCT07298941 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with chronic low back pain for at least three months, average pain ≥4/10, and insomnia symptoms for six months or longer are the intended participants.

Probably not a fit

People currently receiving behavioral insomnia treatment or those who already practice meditation regularly are unlikely to benefit from this study's interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 adaptive interventional study delivers cognitive behavioral therapy for insomnia (CBTi) to adults with chronic low back pain and comorbid insomnia and then augments that treatment with either savoring meditation or structured pain education to determine effects on pain intensity. Participants who meet chronic low back pain and insomnia criteria receive the CBTi program and are assigned to one of the augmentation strategies. The primary outcome is change in pain intensity, and secondary outcomes include insomnia severity, positive and negative affect, and overall quality of life. The trial tests whether targeting sleep plus positive affect produces greater pain reduction than sleep treatment alone.

Why it matters

Potential benefit: If successful, this approach could lower pain intensity and improve sleep and emotional well‑being without adding medications.

How similar studies have gone: CBTi has strong evidence for improving insomnia and has sometimes reduced pain in prior trials, while savoring meditation as a positive‑affect augmentation is relatively novel with limited prior pain‑specific data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

(1) age \>=18 years; (2) report low back pain as ongoing problem \>= 3 months and any pain on at least half of the days over the past 6 months (consistent with NIH Consensus Recommendations, other chronic pain problems can be present, but cLBP must be reported as primary); (3) average pain intensity \>= 4 over past 7 days on a 0-10 numerical rating scale; (4) sleep-onset insomnia and/or sleep maintenance insomnia and/or late insomnia (\>30 minutes of WASO or SOL or waking \>30 minutes before desired time for at least 3 nights/week) with presence of insomnia symptoms for \>= 6 months, and the sleep disturbance (or associated daytime fatigue) must cause significant distress or impairment in social, occupational, or other areas of functioning to be consistent with DSM 5 criteria (evaluated by phone interview).

Exclusion Criteria:

(1) currently receiving behavioral treatment for insomnia; (2) currently engaging in formal or informal meditation practice on a regular (e.g., weekly) basis; (3) unstable medication use for sleep, pain, or other indication (e.g., changed within the past 3 months); (4) irregular sleep schedules dictated by shift work (i.e., usual bedtimes outside 8:00 p.m.-2:00 a.m. or arising time outside 4:00 a.m.-10:00 a.m.); (4) mental health condition deemed to interfere with study procedures or put the participant at undue risk via semi-structured interview (e.g., screen positive for psychotic disorder) or other untreated sleep disorders (e.g., obstructive sleep apnea, restless legs syndrome) as evaluated by our semi-structured interview based on the Diagnostic Interview for Insomnia (DII); (5) do not have regular internet access; (6) cannot read and speak English (interventions only available in English); and (7) severe cognitive impairment (i.e., score =9 on the Telephone-Assessed Mental State); (8) currently pregnant; 9) unable or unwilling to comply with study protocols, or otherwise determined by the PI to be able to safely participate in the study.

Where it's running

  • University of Virginia
    Charlottesville, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Patrick Finan, Ph.D. — University of Virginia School of Medicine
  • Study coordinator: Zayn Shahzad
  • Email: finanlab@uvahealth.org
  • Phone: 434-243-5906

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.